Impact of 12/15-lipoxygenase on brain injury after subarachnoid hemorrhage
Stroke Jan 09, 2019
Gaberel T, et al. - In a mouse model of subarachnoid hemorrhage (SAH), researchers assessed the role of an enzyme known to cause cell death in ischemic stroke, called 12/15-lipoxygenase (12/15-LOX), on brain injury. Using a direct blood injection technique, C57Bl6 wild-type mice and Alox15 knockout mice were subjected to SAH. According to findings, 12/15-LOX is overexpressed in macrophages following SAH in mice and inhibiting the 12/15-LOX pathway reduces brain injury and improves neurological outcome. Researchers feel 12/15-LOX could be a new therapeutic target for reducing brain injury following SAH.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries